| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $32.48 | $190,832.93 | -10.4% | |
| May 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $32.40 | $190,324.15 | -10.4% | |
| Apr 1, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $27.83 | $163,485.98 | -5.5% | |
| Mar 20, 2025 | Hughes Steven George | Chief Medical Officer | Sell | 9,578 | $31.06 | $297,490.76 | -11.6% | |
| Mar 20, 2025 | Boyce Sarah | President And CEO | Sell | 31,540 | $31.06 | $979,563.01 | -9.3% | |
| Mar 20, 2025 | Flanagan W. Michael | Chief Scientific Officer | Sell | 11,780 | $31.06 | $365,867.95 | -12.8% | |
| Mar 20, 2025 | MacLean Michael F | Chief Financial Officer | Sell | 7,935 | $31.06 | $246,424.60 | -7.6% | |
| Mar 20, 2025 | McCarthy Teresa | Chief Human Resources Officer | Sell | 7,778 | $31.06 | $241,583.12 | -7.4% | |
| Mar 11, 2025 | Flanagan W. Michael | Chief Scientific Officer | Sale+OE | 20,000 | $30.13 | $602,614.00 | -17.9% | |
| Mar 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $29.41 | $172,807.25 | -10.4% |